about
Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism.Anxiolytic-like activity of the non-selective galanin receptor agonist, galnonReceptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonistAnxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implicationsHistopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesisLoss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out miceThe Cdkn1a gene (p21Waf1/Cip1) is an inflammatory response gene in the mouse central nervous system.High-throughput confirmation of differential display PCR results using reverse Northern blotting.Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression.Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders.The central vasopressinergic system: examining the opportunities for psychiatric drug development.Social attention: a possible early indicator of efficacy in autism clinical trials.Innovative approaches for the development of antidepressant drugs: current and future strategiesDifferentiating antidepressants of the future: efficacy and safety.Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencingFlow cytometric analysis of BrdU incorporation as a high-throughput method for measuring adult neurogenesis in the mouse.Estrogen receptor neurobiology and its potential for translation into broad spectrum therapeutics for CNS disorders.Assessing behavioural and cognitive domains of autism spectrum disorders in rodents: current status and future perspectives.Whole-genome sequencing of quartet families with autism spectrum disorder.Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder.Brain region specific actions of regulator of G protein signaling 4 oppose morphine reward and dependence but promote analgesia.Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system.Temporal dysregulation of cortical gene expression in the isolation reared Wistar rat.The metabotropic glutamate receptor 7 allosteric modulator AMN082: a monoaminergic agent in disguise?Investigating tonic Wnt signaling throughout the adult CNS and in the hippocampal neurogenic niche of BatGal and ins-TopGal mice.Inhibition of uptake 2 (or extraneuronal monoamine transporter) by normetanephrine potentiates the neurochemical effects of venlafaxine.Transcriptional profiling of brain-derived-neurotrophic factor-induced neuronal plasticity: a novel role for nociceptin in hippocampal neurite outgrowth.Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes--DRD2, D beta H, and DAT1.The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease.Temporal proteomic profile of memory consolidation in the rat hippocampal dentate gyrus.A complicated picture of oxytocin action in the central nervous system revealed.Increasing the levels of insulin-like growth factor-I by an IGF binding protein inhibitor produces anxiolytic and antidepressant-like effects.Preclinical Animal Models of Autistic Spectrum Disorders (ASD)Translational Neuroimaging for Drug Discovery and Development in Autism Spectrum DisordersEditorialHyperpolarization-activated cyclic nucleotide-gated channel mRNA and protein expression in large versus small diameter dorsal root ganglion neurons: Correlation with hyperpolarization-activated current gating
P50
Q27329063-B5B86281-D93E-46C3-9D14-5DA0F15D55F7Q28236884-B61A13D5-2827-4BB5-8A74-14C8874D0A26Q28252450-A8FFB97A-2BC6-4E1C-A613-D107DD2179C0Q28292344-45F3D662-9D08-4EEC-B5F7-F6648727472EQ28390236-E27197D5-3AE5-41D8-8253-90A9E99F285DQ28591248-D65884BD-14D2-4CDF-A634-E50C14413CCDQ30981644-334D5AFF-92DC-464E-BC2C-F7356ADE8AC9Q34176761-EB41ADF2-D08C-4099-9F80-66932F992058Q34272354-B6102090-76D8-435F-A481-3162C40DE56DQ34756930-433128FE-09D2-4163-9907-2CAADDC940CEQ36002857-80FC66ED-BCC9-459D-88FE-6B678EA9407CQ36217717-BEDAE46D-9B1D-4C21-BD88-A2E4972628ADQ36401400-6985319E-D7C0-433B-837E-C41A777F4EB8Q36607652-7007D76A-0EA0-4909-8A33-04D60079B293Q37083418-3BFF085F-6B73-4B3D-9B1B-519CE0D7FC0CQ37240750-8B51A96F-D051-4A9A-A188-3CECC0FAB536Q37659177-2E25AE83-C87F-49CB-8242-BC79719F2D85Q38139257-415C0E2B-FAF2-424D-8896-E0AF6347261AQ41525456-F5EF1D39-493F-4246-B505-AD72513CCC52Q41654153-8975A00B-9601-4280-A0F3-881CB60A47E8Q42601949-1E73A2F3-35D3-4983-B8FE-F9105BBB06FCQ42882543-B58291B1-51A7-465E-BD78-C6D5726DD434Q43185829-89E0C68E-A498-43B5-B440-A80396D19703Q44369820-9EAC5C34-D2CD-44CA-ADE2-8F03F1607572Q46292185-C27EB64F-3655-4CA4-A9E3-2B06C6036356Q46717701-ED2BA4BA-B83B-418F-AF3A-1E791D5604CCQ46891228-437FF2A5-DEE7-4B98-998A-DF562D848841Q47632246-EE8E58AD-1086-4834-9E4B-1FDFF10F490BQ48254282-E8387806-83A3-4876-A9FE-04505E3F0262Q48834842-9256E39E-83B9-4C8F-A25E-9A188D55F6ECQ50311382-44BCA0F3-45A7-404E-B075-0D402B05891AQ50907929-4E135574-E1C0-42EB-A1C8-6820623C5E02Q57279152-1B4B56CF-CAE9-4F42-A96E-F91545525F8BQ63869329-B8A2114F-7BEC-4E37-9EE6-4C61C6A238A3Q63869330-C60F69B5-2966-4046-881F-8DB3B31BF4A3Q63869331-57F2507A-390A-4233-B5A7-3A2EB3CD2843
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Robert H. Ring
@ast
Robert H. Ring
@en
Robert H. Ring
@es
Robert H. Ring
@nl
Robert H. Ring
@sl
type
label
Robert H. Ring
@ast
Robert H. Ring
@en
Robert H. Ring
@es
Robert H. Ring
@nl
Robert H. Ring
@sl
prefLabel
Robert H. Ring
@ast
Robert H. Ring
@en
Robert H. Ring
@es
Robert H. Ring
@nl
Robert H. Ring
@sl
P1053
M-1238-2016
P106
P108
P1153
7006366003
P21
P31
P3829
P496
0000-0002-7037-4409